Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment
The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups. For 60 days, Group I received mildronate, 1.0 g/d, Group II - preductal MV (trimetazidin...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2007-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2082 |
| _version_ | 1797857245741973504 |
|---|---|
| author | G. G. Semenkova L. V. Kokoreva |
| author_facet | G. G. Semenkova L. V. Kokoreva |
| author_sort | G. G. Semenkova |
| collection | DOAJ |
| description | The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups. For 60 days, Group I received mildronate, 1.0 g/d, Group II - preductal MV (trimetazidine), 60 mg/d, in addition to standard treatment. Control group received standard treatment only (n=20). Clinical examination was performed at Days 1, 14, and 60. Therapy effectiveness was assessed by subjective, objective, laboratory and instrumental data dynamics. In mildronate group, the parameters assessed had improved significantly, comparing to control and preductal MV groups. |
| first_indexed | 2024-04-09T20:53:34Z |
| format | Article |
| id | doaj.art-cac5a769549c4e9389c4c56647d48594 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:53:34Z |
| publishDate | 2007-04-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-cac5a769549c4e9389c4c56647d485942023-03-29T21:23:14Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202007-04-010277821836Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatmentG. G. Semenkova0L. V. Kokoreva1Воронежская государственная медицинская академия им. Н.Н. БурденкоВоронежская государственная медицинская академия им. Н.Н. БурденкоThe study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups. For 60 days, Group I received mildronate, 1.0 g/d, Group II - preductal MV (trimetazidine), 60 mg/d, in addition to standard treatment. Control group received standard treatment only (n=20). Clinical examination was performed at Days 1, 14, and 60. Therapy effectiveness was assessed by subjective, objective, laboratory and instrumental data dynamics. In mildronate group, the parameters assessed had improved significantly, comparing to control and preductal MV groups.https://russjcardiol.elpub.ru/jour/article/view/2082chronic heart failuremyocardial cytoprotectorstherapy effectiveness |
| spellingShingle | G. G. Semenkova L. V. Kokoreva Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment Российский кардиологический журнал chronic heart failure myocardial cytoprotectors therapy effectiveness |
| title | Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| title_full | Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| title_fullStr | Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| title_full_unstemmed | Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| title_short | Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| title_sort | comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment |
| topic | chronic heart failure myocardial cytoprotectors therapy effectiveness |
| url | https://russjcardiol.elpub.ru/jour/article/view/2082 |
| work_keys_str_mv | AT ggsemenkova comparativeeffectivenessofmyocardialcytoprotectorsinchronicheartfailuretreatment AT lvkokoreva comparativeeffectivenessofmyocardialcytoprotectorsinchronicheartfailuretreatment |